Literature DB >> 29570354

Predictors of Clinical Outcomes After Hip Arthroscopy: A Prospective Analysis of 1038 Patients With 2-Year Follow-up.

Benjamin G Domb1,2, Timothy J Martin1, Chengcheng Gui1, Sivashankar Chandrasekaran1, Carlos Suarez-Ahedo1, Parth Lodhia1.   

Abstract

BACKGROUND: As hip arthroscopy has expanded in popularity and volume, more information is needed about indications for the procedure and the predictive factors of clinical outcomes.
PURPOSE: To evaluate clinical outcomes of hip arthroscopy in a prospective study and to analyze the cohort to identify factors that are predictive of improvement. STUDY
DESIGN: Case-control study; Level of evidence, 3.
METHODS: Data were collected prospectively on all patients undergoing hip arthroscopy between February 2008 and June 2012. We included all patients undergoing hip arthroscopy who agreed to participate and who completed 4 patient-reported outcome (PRO) instruments at a minimum 2-year follow-up: the modified Harris Hip Score (mHHS), Nonarthritic Hip Score (NAHS), Hip Outcome Score-Activities of Daily Living (HOS-ADL), and Hip Outcome Score-Sport-Specific Subscale. The NAHS was selected as our primary outcome instrument. All patients with any previous hip conditions were excluded. We analyzed 34 preoperative and intraoperative variables using bivariate and multivariate analyses compared with NAHS.
RESULTS: The cohort consisted of 1038 patients with a mean follow-up of 30.1 months (range, 24.0-61.2 months). Mean age was 36.4 years (range, 13.2-76.4 years). All postoperative PRO scores showed significant improvement ( P < .001) at 2 years compared with preoperative scores. Bivariate analysis identified 15 variables (7 categorical and 8 continuous) and multivariate analysis identified 10 variables that were predictive of 2-year postoperative NAHS. Preoperative NAHS, preoperative HOS-ADL, preoperative mHHS, age, duration of symptoms, body mass index (BMI), and revision hip arthroscopy were identified as predictive factors in both bivariate and multivariate analyses. The predictive value of preoperative NAHS was accentuated for patients with higher BMI.
CONCLUSION: This study reports favorable clinical outcomes in the largest cohort of hip arthroscopies with a minimum 2-year follow-up in the literature to date. Factors identified as predictive in both bivariate and multivariate analyses included preoperative NAHS, HOS-ADL, and mHHS; age; duration of symptoms; BMI; and revision hip arthroscopy. These predictive factors may be useful to the clinician in determining prognosis and operative indications for hip arthroscopy.

Entities:  

Keywords:  Nonarthritic Hip Score; clinical outcomes; hip arthroscopy; patient-reported outcomes; predictive factors

Mesh:

Year:  2018        PMID: 29570354     DOI: 10.1177/0363546518763362

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  19 in total

1.  Validity of direct magnetic resonance arthrogram in patients with femoroacetabular impingement and their outcome post hip arthroscopy.

Authors:  Rahul Mohan; P Nithin Unnikrishnan; Ravindra Gudena
Journal:  J Orthop       Date:  2019-11-12

2.  The Impact of Pre-Operative Healthcare Utilization on Complications, Readmissions, and Post-Operative Healthcare Utilization Following Total Joint Arthroplasty.

Authors:  Ashley E Creager; Andrew D Kleven; Ziynet Nesibe Kesimoglu; Austin H Middleton; Meaghan N Holub; Serdar Bozdag; Adam I Edelstein
Journal:  J Arthroplasty       Date:  2021-11-15       Impact factor: 4.757

3.  The minimal clinically important difference for the nonarthritic hip score at 2-years following hip arthroscopy.

Authors:  David A Bloom; Daniel J Kaplan; David J Kirby; Daniel B Buchalter; Charles C Lin; Jordan W Fried; Nainisha Chintalapudi; Thomas Youm
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-11-05       Impact factor: 4.342

4.  Hip arthroscopy for femoroacetabular impingement is associated with significant improvement in early patient reported outcomes: analysis of 4963 cases from the UK non-arthroplasty registry (NAHR) dataset.

Authors:  Richard Holleyman; Mark Andrew Sohatee; Stephen Lyman; Ajay Malviya; Vikas Khanduja
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-07-14       Impact factor: 4.114

5.  Performance and Return to Sport After Hip Arthroscopic Surgery in Major League Baseball Players.

Authors:  Robert A Jack; Kyle R Sochacki; Takashi Hirase; Justin Vickery; Patrick C McCulloch; David M Lintner; Joshua D Harris
Journal:  Orthop J Sports Med       Date:  2019-02-22

Review 6.  Predictors of Outcomes After Hip Arthroscopic Surgery for Femoroacetabular Impingement: A Systematic Review.

Authors:  Olawale A Sogbein; Ajay Shah; Jeffrey Kay; Muzammil Memon; Nicole Simunovic; Etienne L Belzile; Olufemi R Ayeni
Journal:  Orthop J Sports Med       Date:  2019-06-19

7.  Do Not Take for Granted! The Art of Elevating the Capsule in Hip Arthroscopy: A Stepwise Approach.

Authors:  David R Maldonado; Jeffrey W Chen; Ajay C Lall; Cynthia Kyin; Rafael Walker-Santiago; Philip J Rosinsky; Jacob Shapira; Benjamin G Domb
Journal:  Arthrosc Tech       Date:  2019-08-01

Review 8.  Influence of Femoral Version on the Outcomes of Hip Arthroscopic Surgery for Femoroacetabular Impingement or Labral Tears: A Systematic Review and Meta-analysis.

Authors:  Chenghui Wang; Yaying Sun; Zheci Ding; Jinrong Lin; Zhiwen Luo; Jiwu Chen
Journal:  Orthop J Sports Med       Date:  2021-06-10

9.  What is the Role of Kinesiophobia and Pain Catastrophizing in Outcomes After Hip Arthroscopy for Femoroacetabular Impingement Syndrome?

Authors:  Ian M Clapp; Benedict U Nwachukwu; Edward C Beck; Jonathan P Rasio; Thomas Alter; Bradley Allison; Shane J Nho
Journal:  Arthrosc Sports Med Rehabil       Date:  2020-01-08

Review 10.  Cost-Effectiveness of Hip Arthroscopy for Treatment of Femoroacetabular Impingement Syndrome and Labral Tears: A Systematic Review.

Authors:  Cammille C Go; Cynthia Kyin; Jeffrey W Chen; Benjamin G Domb; David R Maldonado
Journal:  Orthop J Sports Med       Date:  2021-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.